These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20661012)

  • 1. Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases.
    Roh JH; Srivastava A; Lauwers GY; An J; Jang KT; Park CK; Sohn TS; Kim S; Kim KM
    Am J Surg Pathol; 2010 Aug; 34(8):1139-46. PubMed ID: 20661012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
    Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
    Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis.
    Zhang Q; Ming J; Zhang S; Li B; Yin L; Qiu X
    Gastric Cancer; 2015 Jan; 18(1):93-9. PubMed ID: 24562421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
    Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
    Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 status in unusual histological variants of gastric adenocarcinomas.
    Giuffrè G; Ieni A; Barresi V; Caruso RA; Tuccari G
    J Clin Pathol; 2012 Mar; 65(3):237-41. PubMed ID: 22067088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
    Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
    Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric carcinoma with an invasive micropapillary carcinoma component showing HER2 gene amplification and CD10 expression: a case report and review of the literature.
    Tajima S; Kodama H; Kamiya T; Terasaki M
    Pathol Int; 2014 Aug; 64(8):402-8. PubMed ID: 25143129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
    Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
    Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
    Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix.
    Yajima N; Wada R; Yamagishi S; Mizukami H; Itabashi C; Yagihashi S
    Hum Pathol; 2005 Nov; 36(11):1217-25. PubMed ID: 16260276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study.
    Triantafillidou K; Iordanidis F; Psomaderis K; Kalimeras E
    J Oral Maxillofac Surg; 2010 Oct; 68(10):2489-96. PubMed ID: 20678839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
    Zhang J; Liang ZY; Luo YF; Wan JW; Cao JL; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):651-6. PubMed ID: 20078967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical markers in the morphological diagnosis of lung carcinoma.
    Cornianu M; Tudose N
    Rom J Morphol Embryol; 1997; 43(3-4):181-91. PubMed ID: 9747120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
    Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.